| Safdar Ghayur Khan, MD | |
|
1000 Breckenridge St Ste 300, Owensboro, KY 42303-0877 | |
| (270) 685-7150 | |
| (270) 685-7173 |
| Full Name | Safdar Ghayur Khan |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 35 Years |
| Location | 1000 Breckenridge St Ste 300, Owensboro, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467693317 | NPI | - | NPPES |
| 000000609731 | Other | KY | ANTHEM PIN # WITH CHS, INC. |
| 7100093900 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 42375 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairview Hospital | Cleveland, OH | Hospital |
| Cleveland Clinic | Cleveland, OH | Hospital |
| Cleveland Clinic Avon Hospital | Avon, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
A new study of mutations in cancer genomes shows how researchers can begin to distinguish the 'driver' mutations that push cells towards cancer from the 'passenger' mutations that are a by-product of cancer cell development. The study also shows that at least one in nine genes can be removed without killing human cells.
A clinical study funded by the National Institutes of Health has found that young, single black women in South Africa adhered to a daily pill regimen to prevent HIV infection-an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. This finding is the first strong indication that this population at substantial HIV risk could accept and reliably adhere to daily PrEP dosing.
A new study led by the Sainte-Justine University Hospital Centre and the University of Montreal, along with the Washington University School of Medicine in St. Louis, has found that transfusions using fresh red blood cells-cells that have spent seven days or less in storage-are no more beneficial than older red blood cells in reducing the risk of organ failure or death in critically ill children.
Imagine a day when a bioprinter filled with a patient's own cells can be wheeled right to the bedside to treat large wounds or burns by printing skin, layer by layer, to begin the healing process. That day is not far off.
Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.
› Verified 5 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
A new study of mutations in cancer genomes shows how researchers can begin to distinguish the 'driver' mutations that push cells towards cancer from the 'passenger' mutations that are a by-product of cancer cell development. The study also shows that at least one in nine genes can be removed without killing human cells.
A clinical study funded by the National Institutes of Health has found that young, single black women in South Africa adhered to a daily pill regimen to prevent HIV infection-an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. This finding is the first strong indication that this population at substantial HIV risk could accept and reliably adhere to daily PrEP dosing.
A new study led by the Sainte-Justine University Hospital Centre and the University of Montreal, along with the Washington University School of Medicine in St. Louis, has found that transfusions using fresh red blood cells-cells that have spent seven days or less in storage-are no more beneficial than older red blood cells in reducing the risk of organ failure or death in critically ill children.
Imagine a day when a bioprinter filled with a patient's own cells can be wheeled right to the bedside to treat large wounds or burns by printing skin, layer by layer, to begin the healing process. That day is not far off.
Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Safdar Ghayur Khan, MD 1000 Breckenridge St Ste 300, Owensboro, KY 42303-0877 Ph: (270) 685-7150 | Safdar Ghayur Khan, MD 1000 Breckenridge St Ste 300, Owensboro, KY 42303-0877 Ph: (270) 685-7150 |
News Archive
A new study of mutations in cancer genomes shows how researchers can begin to distinguish the 'driver' mutations that push cells towards cancer from the 'passenger' mutations that are a by-product of cancer cell development. The study also shows that at least one in nine genes can be removed without killing human cells.
A clinical study funded by the National Institutes of Health has found that young, single black women in South Africa adhered to a daily pill regimen to prevent HIV infection-an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. This finding is the first strong indication that this population at substantial HIV risk could accept and reliably adhere to daily PrEP dosing.
A new study led by the Sainte-Justine University Hospital Centre and the University of Montreal, along with the Washington University School of Medicine in St. Louis, has found that transfusions using fresh red blood cells-cells that have spent seven days or less in storage-are no more beneficial than older red blood cells in reducing the risk of organ failure or death in critically ill children.
Imagine a day when a bioprinter filled with a patient's own cells can be wheeled right to the bedside to treat large wounds or burns by printing skin, layer by layer, to begin the healing process. That day is not far off.
Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.
› Verified 5 days ago
David B. Olalekan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1201 Pleasant Valley Rd, Owensboro, KY 42303 Phone: 270-417-4700 Fax: 270-417-4709 | |
Dr. Jacob S. Hodskins, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Breckenridge St, Suite 400, Owensboro, KY 42303 Phone: 270-688-3445 Fax: 270-688-3344 | |
Dr. Adrian James Yeiser, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 811 E Parrish Ave, Owensboro, KY 42303 Phone: 270-688-3371 Fax: 270-688-3370 | |
Dr. Roshan K. Mathew, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3110 Fairview Dr, Owensboro, KY 42303 Phone: 270-240-2129 | |
Madison P Hardesty, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1201 Pleasant Valley Rd, Owensboro, KY 42303 Phone: 270-417-4700 Fax: 270-417-4709 | |
Dr. David M Brey, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Breckenridge St Ste 303, Owensboro, KY 42303 Phone: 270-688-5100 Fax: 270-688-5109 | |
Mahesh K. Moolani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Breckenridge St, Owensboro, KY 42303 Phone: 270-685-8224 Fax: 270-685-8228 |